<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05629403</url>
  </required_header>
  <id_info>
    <org_study_id>NanjingMU2022</org_study_id>
    <nct_id>NCT05629403</nct_id>
  </id_info>
  <brief_title>Exclusive Breastfeeding Improves Puerperal Glucose Metabolism in Pregnant Women With Gestational Diabetes Mellitus and Links to Lipids Composition</brief_title>
  <official_title>Women's Hospital of Nanjing Medical University</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanjing Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Breastfeeding could effectively be associated with a lower risk of future type 2 diabetes&#xD;
      (T2D) in women with gestational diabetes mellitus (GDM), but the short-term protective impact&#xD;
      of puerperal breastfeeding on maternal metabolic recovery of GDM women remains unascertained.&#xD;
      The investigators recruited GDM participants at 6-9 weeks postpartum and retrieved clinical&#xD;
      diagnoses of GDM from electronic medical records. Feeding patterns were collected via phone&#xD;
      calls. Glucose metabolism parameters and lipid profiling were performed on fasting plasma&#xD;
      samples collected from patients 6-9 weeks postpartum (20 breastfeeding cases vs. 15 formula&#xD;
      feeding cases).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Actual">July 1, 2022</completion_date>
  <primary_completion_date type="Actual">March 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>glucose</measure>
    <time_frame>At 6-8 weeks postpartum</time_frame>
    <description>glucose (mmol/L) determined with human ELISA kits</description>
  </primary_outcome>
  <primary_outcome>
    <measure>insulin</measure>
    <time_frame>At 6-8 weeks postpartum</time_frame>
    <description>insulin (mU/L) determined with human ELISA kits</description>
  </primary_outcome>
  <primary_outcome>
    <measure>c-peptide</measure>
    <time_frame>At 6-8 weeks postpartum</time_frame>
    <description>c-peptide (ng/m) determined with human ELISA kits</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HOMA-IR</measure>
    <time_frame>At 6-8 weeks postpartum</time_frame>
    <description>fasting glucose and fasting glucose will be combined to report HOMA-IR</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">84</enrollment>
  <condition>Gestational Diabetes</condition>
  <condition>Breast Feeding</condition>
  <condition>Lipid Metabolism Disorders</condition>
  <arm_group>
    <arm_group_label>exclusive breastfeeding</arm_group_label>
    <description>breastfeeding exclusively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>formula feeding</arm_group_label>
    <description>formula feeding</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>observe</intervention_name>
    <description>no intervention</description>
    <arm_group_label>exclusive breastfeeding</arm_group_label>
    <arm_group_label>formula feeding</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        women (aged 18-35 years) who delivered live-born infants equal to or greater than 37 weeks&#xD;
        of gestation at the Women's Hospital of Nanjing Medical University (Nanjing, China) and&#xD;
        were not using medications affecting glucose tolerance, lipid regulation and not planning&#xD;
        another pregnancy within the next 2 years were enrolled. All the participants received 75g&#xD;
        OGTT at 24-28 weeks of gestation and were diagnosed with GDM based on the IADPSG criteria&#xD;
        (International Association of Diabetes and Pregnancy Study Groups Consensus Panel et al.).&#xD;
        At 6-8 weeks postpartum, all the participants were administered regularly for a post-natal&#xD;
        health check-up to classify the body and genitals basically restored status. Fasting plasma&#xD;
        samples were collected to measure plasma glucose, and insulin, and reclassify glucose&#xD;
        metabolic status. Frequency and amount of breastmilk feeding and formula feeding for each&#xD;
        woman were evaluated by trained research staff via telephone calls.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 18-35 years old;&#xD;
&#xD;
          2. gestational age greater than 37 weeks;&#xD;
&#xD;
          3. Body Mass Index (BMI) before pregnancy 18.5-28kg/m2;&#xD;
&#xD;
          4. Have normal listening and speaking skills, can communicate, and are willing to&#xD;
             participate in this study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. abnormal glucose metabolism or diabetes has been diagnosed before pregnancy;&#xD;
&#xD;
          2. assisted reproduction;&#xD;
&#xD;
          3. GDM patients requiring drug treatment;&#xD;
&#xD;
          4. The use of blood lipid regulation drugs;&#xD;
&#xD;
          5. other pregnancy complications and complications;&#xD;
&#xD;
          6. Suffering from heart, malignant tumor, kidney and other major organ diseases;&#xD;
&#xD;
          7. associated with neurological dysfunction and cognitive impairment;&#xD;
&#xD;
          8. Failure to cooperate with follow-up observers.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nanjing Maternal and child Health Care Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>21004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>July 7, 2022</study_first_submitted>
  <study_first_submitted_qc>November 27, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2022</study_first_posted>
  <last_update_submitted>November 27, 2022</last_update_submitted>
  <last_update_submitted_qc>November 27, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nanjing Medical University</investigator_affiliation>
    <investigator_full_name>Xirong Guo</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Lipid Metabolism Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

